Versartis to Present at the 2014 Credit Suisse Healthcare Conference

World News: . []

MENLO PARK Calif Nov 5 2014 GLOBE NEWSWIRE -- Versartis Inc NasdaqVSAR an endocrine-focused biopharmaceutical company that is developing a novel long-acting form of recombinant human growth hormone rhGH today announced that Jeffrey L. Clel...

More news and information about Versartis

Published By:

Globe Newswire: 13:30 GMT Wednesday 5th November 2014

Published: .

Search for other references to "versartis" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us